Skip to content
Open access

Wearable Gait Biomarkers and Explainable AI Identify High Retrospective Prodromal Burden in Parkinson’s Disease

Sep 2026 · Scientific Reports · 0 citations

Abstract

Objective wearable markers of Parkinson’s disease (PD) progression and phenotypic heterogeneity remain clinically relevant, particularly in relation to the burden of non-motor features that often precede or accompany the motor diagnosis. In patients with established PD, the retrospective accumulation of prodromal symptoms may identify a clinically meaningful subgroup with broader multisystem involvement. This study developed an interpretable machine-learning framework using wearable inertial gait data to model high retrospective prodromal burden within established PD, defined as the anamnestic presence of at least three prodromal symptoms. A total of 274 individuals with PD performed 30-m walking trials using a single lumbar inertial sensor. Thirty-five biomechanical and clinical variables were extracted, and feature selection identified five key predictors: multiscale entropy ( $$\:MSE$$ ) along three axes, vertical improved harmonic ratio ( $$\:{iHR}_{v}$$ ), and body weight. A Random Forest classifier balanced through CTGAN-based training-set augmentation reached a cross-validated ROC AUC of 0.84 ( $$\:{PR}_{AUC}$$ = 0.86, $$\:F1-score$$ = 0.76); on the untouched real held-out test set, discrimination was $$\:{ROC}_{AUC}$$ = 0.74 and $$\:{PR}_{AUC}$$ = 0.71, consistent with an internally developed phenotyping model requiring external validation. Explainability analyses highlighted that increased $$\:MSE$$ and reduced $$\:{iHR}_{v}$$ were the strongest contributors to high retrospective prodromal burden, indicating elevated gait complexity and altered spatio-temporal symmetry. These findings delineate an interpretable gait phenotype associated with high retrospective prodromal burden in established PD, supporting wearable gait analysis as a tool for within-PD digital phenotyping.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.